A new study presented at the European Respiratory Society Conference in Vienna suggests that popular epilepsy drug Sulthiame ...

The magnitude was much greater in children than adults, and central sleep apnea was tied to greater risk than obstructive sleep apnea.

An epilepsy drug could help ... Sulthiame, a drug sold under the brand name Ospolot, appeared to reduce symptoms of obstructive sleep apnoea in a recent international clinical trial of 298 patients.

A late-stage trial of Eli Lilly’s weight loss drug Zepbound showed promising ... to help people lose weight likely helped reduce sleep apnea events, as participants in either trial lost about ...

Epilepsy Drug Shows Promise in Reducing Obstructive Sleep Apnea Symptoms This article summarized ... brand name Ospolot in Europe, appeared to reduce symptoms of OSA. The researchers found that ...